While NSAIDs and TNF inhibitors were not associated with a significant increase in cardiovascular events, selective COX-2 inhibitors showed a trend toward reducing coronary event risk in AS patients.
← all excerpts
MMP3 as a Molecular Link: Unraveling the Connection Between Ankylosing Spondylitis and Acute Coronary Syndrome.
1
—
—